Ticker
VIVSCompany Name
VIVOSIM LABS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Cash and Equivalents | Cash to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 11.98M | $ 9.2M | 76.79% |
3/31/2025 | $ 14.65M | $ 11.46M | 78.19% |
12/31/2024 | $ 3.84M | $ 1.3M | 33.92% |
9/30/2024 | $ 6.75M | $ 3.32M | 49.11% |
6/30/2024 | $ 9.47M | $ 6.33M | 66.84% |
3/31/2024 | $ 6.35M | $ 3.04M | 47.94% |
12/31/2023 | $ 8.88M | $ 5.44M | 61.23% |
9/30/2023 | $ 11.16M | $ 7.76M | 69.53% |
6/30/2023 | $ 14.76M | $ 10.9M | 73.85% |
3/31/2023 | $ 20.31M | $ 15.44M | 76.03% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for VIVOSIM LABS INC is calculated as follows: CashnEq [ $ 17.66M ] / Assets [ $ 20.64M ]
(=) Cash to Assets [ 85.53% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.94K |
---|---|
min | 0% |
max | 40.71% |
average | 9.76% |
median | 6.41% |
std | 9.51% |